Sign in
4

Changes in Ownership

Kairos Pharma, LTD. Filed Acc 0001493152-25-025197

CEO and Chairman acquired 190,840 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Yu John S · CEO and Chairman

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-10-08 Grant or award : show line 1 in the form +190,840 230,105 D
Loading xslF345X05/ownership.xml…